![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CORGENIX LAUNCHES NEXT GENERATION PREDICTIVE CARDIOVASCULAR DIAGNOSTIC LINE
CORGENIX LAUNCHES NEXT GENERATION PREDICTIVE CARDIOVASCULAR DIAGNOSTIC LINE
September 14, 2005
Corgenix Medical Corporation (OTCBB:CONX - News),
a worldwide marketer of diagnostic test kits, announces the launch of AtherOx,
a next generation product line utilizing patented technology to identify individuals
at risk for developing atherosclerotic cardiovascular disease. The AtherOx
technology is a novel diagnostic product that measures oxidized Low-Density
Lipoprotein (oxLDL) complexed with a plasma protein known as B2GP1, which combined
functions as a specific marker of potential cardiovascular disease.
Yahoo
News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct